Divis Laboratories Ltd | DIVI - Ordinary Share Capital


Divis Laboratories Ltd reported INR265.47M in Ordinary Share Capital for its fiscal quarter ending in September of 2026.





Ordinary Share Capital Change Date
Alaunos Therapeutics USD 2.49M 108K Jun/2026
Aurobindo Pharma INR 575.38M 5.42M Sep/2026
Dianthus Therapeutics USD 54.8M 215.59K Jun/2026
Divis Laboratories Ltd INR 265.47M 0 Sep/2026
Ionis Pharmaceuticals USD 166.41M 773K Sep/2026
IQVIA Holdings USD 164.8M 200K Sep/2026
Lupin INR 457.29M 111K Sep/2026
Moderna USD 391M 2M Sep/2025
Organon & Co USD 262.62M 13K Sep/2026
Revvity USD 111.59M 43K Sep/2026
Tectonic Therapeutic USD 19.24M 404.78K Jun/2026
Tilray USD 116.52M 5.01M Sep/2025
Viatris USD 1.15B 8.79M Sep/2026
Xeris Pharmaceuticals USD 173.59M 1.03M Jun/2026